| Name | Title | Contact Details |
|---|
Paramus Surgical Ctr is a Paramus, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lightning Step is the only all-in-one enterprise software for behavioral health and addiction treatment centers created by treatment professionals. The solution brings together the fundamentals required to operate and grow a successful facility in today`s world, integrating CRM, EMR, and RCM systems and removing the cross-communication pain points of using multiple platforms. Enjoy a smoother operation with one system, one login, one price.
Infinity Rehab is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Infinity Rehab is based in Wilsonville, OR. You can find more information on Infinity Rehab at www.infinityrehab.com
MMM Healthcare is a San Juan, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.